Substantial advances have been made in the treatment of chronic hepatitis B in the past decade. Approved treatments for chronic hepatitis B include 2 formulations of interferon and 4 nucleos(t)ide analogues (NAs). Sustained viral suppression is rarely achieved after withdrawal of a 48-week course of
✦ LIBER ✦
Current Management of HBV Antiviral Drug Resistance
✍ Scribed by Pietro Lampertico; Mauro Viganò; Massimo Colombo
- Book ID
- 107540567
- Publisher
- Current Science Inc.
- Year
- 2011
- Tongue
- English
- Weight
- 172 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1540-3416
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Antiviral drug-resistant HBV: Standardiz
✍
Anna S. Lok; Fabien Zoulim; Stephen Locarnini; Angeline Bartholomeusz; Marc G. G
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 231 KB
HBV Drug Resistance Development, Testing
✍
Xiangdong David Ren; Hui Nie; Ju-Tao Guo
📂
Article
📅
2010
🏛
Current Science Inc.
🌐
English
⚖ 164 KB
Antiviral drugs: A step ahead of drug re
✍
Rowan, Alison
📂
Article
📅
2005
🏛
Nature Publishing Group
🌐
English
⚖ 106 KB
Resistance of HBV to adefovir dipivoxil:
✍
Costica Aloman; Jack R. Wands
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 64 KB
Background & Aims: Adefovir dipivoxil effectively inhibits both hepatitis B virus (HBV) replication and disease activity in patients with chronic hepatitis B. Resistance to treatment was not observed in 2 recent large placebo-controlled 48-week studies with this drug. The aim of this study was to ch
Mechanisms of drug resistance to current
✍
Jean-Michel Pawlotsky
📂
Article
📅
2004
🏛
Current Science Inc.
🌐
English
⚖ 453 KB
Molecular virology and drug resistance i
✍
Vincent Wai-Sun Wong; Henry Lik-Yuen Chan
📂
Article
📅
2005
🏛
Current Science Inc.
🌐
English
⚖ 277 KB